儿童青少年精神医学:挑战、解决方案、机遇与未来方向
本文指出全球儿童青少年可诊断精神障碍的平均时点患病率高于11%,约半数重性精神障碍在18岁前起病。文章系统梳理了诊断、污名、服务可及性、专业人员短缺、循证治疗、治疗依从性、父母参与、学校整合、数字影响与网络欺凌、战争与被迫流离失所等挑战及可能的解决方案,并讨论了早期识别与干预、韧性、跨学科合作、初级保健整合、社区方法、数字技术、精准儿童青少年精神医学、人工智能与伦理问题、文化多样性与胜任力等机遇与发展方向。尽管儿童青少年精神障碍影响重大,临床服务与预防/早期干预研究仍投入不足、优先级偏低,需要多层次策略、充足培训的人力、适当政策和公众意识提升,以及紧急行动和全球资金再平衡。
要点
- 全球儿童青少年可诊断精神障碍平均时点患病率高于11%,约半数重性精神障碍18岁前起病。
- 诊断、污名、服务可及性、专业人员短缺、治疗依从性、学校整合、数字影响与战争流离失所是核心挑战。
- 临床服务与预防/早期干预研究仍投入不足、优先级偏低,需多层次策略与全球资金再平衡。
核心结论
- 儿童青少年精神障碍负担重且起病早,但临床服务与研究投入不足、优先级偏低。
- 应对需多层次策略,包括结构性与社会经济障碍、韧性、培训人力、政策与公众意识。
- 当前差距需要紧急行动和全球资金再平衡。
研究设计与样本
- 本文为World Psychiatry发表的综述/立场性文章,识别并讨论儿童青少年精神医学的核心挑战、可能的解决方案、机遇与未来方向。
- 文章分为两部分:第一部分讨论诊断、污名、服务可及性、专业人员短缺、循证治疗、治疗依从性、父母参与、学校整合、数字影响与网络欺凌、战争/被迫流离失所等挑战及可能的解决方案;第二部分讨论早期识别与干预、韧性、跨学科合作、初级保健整合、社区方法、数字技术、精准儿童青少年精神医学、人工智能与伦理、文化多样性与胜任力等机遇与发展。
主要发现
- 全球儿童青少年可诊断精神障碍的平均时点患病率高于11%。
- 约半数重性精神障碍病例在18岁前起病。
- 儿童青少年起病的精神障碍对发育中的大脑、身体、个人认同及短期和长期社会、教育、功能能力有巨大影响。
- 儿童青少年精神医学作为学科、专业、学术领域和临床服务网络仍相对年轻,正式演变始于20世纪。
- 尽管影响重大,儿童青少年精神障碍的临床服务与预防/早期干预研究仍投入不足、优先级偏低,即使在 high-income countries(高收入国家)亦如此。
关键数值与推荐
- 全球儿童青少年可诊断精神障碍平均时点患病率高于11%。
- 约半数重性精神障碍在18岁前起病。
临床怎么用
- 临床服务应关注诊断、污名、服务可及性、专业人员短缺、循证治疗、治疗依从性、父母参与、学校整合、数字影响与网络欺凌、战争/被迫流离失所等挑战。
- 可发展早期识别与干预、韧性、跨学科合作、初级保健整合、社区方法、数字技术、精准儿童青少年精神医学、人工智能与伦理、文化多样性与胜任力等方向。
- 需要多层次策略,超越个体治疗,解决结构性与社会经济障碍,创造增强韧性与福祉的机会。
- 需要训练有素的人力、适当政策和公众意识提升。
局限性
- 本文未报告系统检索策略、纳入排除标准或原始研究数据。
- 本文未报告具体研究样本量、效应量、置信区间或P值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
It is estimated that, globally, the mean point prevalence of diagnosable mental disorders in children and adolescents is higher than 11%, and around half of cases of major mental disorders have their onset before the age of 18. Mental disorders with onset in childhood or adolescence have an enormous impact on the developing brain, body and personal identity, as well as on the short- and long-term social, educational and functional capacity of individuals. Child and adolescent psychiatry - as a discipline, profession, academic field, and network of clinical services - is still relatively young, with its formal evolution beginning in the 20th century. Therefore, it is not surprising that there are currently many challenges, but also opportunities and expected future developments, in this area. In this paper, we identify and address the core challenges, possible solutions, opportunities, and future directions of child and adolescent psychiatry. In the first part of the paper, challenges and possible solutions are discussed regarding diagnostic issues, stigma, access to care, shortage of mental health professionals, evidence-based treatments, treatment adherence, parental participation/engagement, integration with schools, digital influences and cyberbullying, and war/forced displacement. In the second part, opportunities and developments are addressed that relate to early identification and intervention, resilience, interdisciplinary collaborations, integration with primary care, community-based approaches, use of digital technologies, precision child and adolescent psychiatry, artificial intelligence and related ethical issues, and cultural diversity and competences. Despite the significance and impact of mental disorders in children and adolescents, clinical delivery and research on these conditions remain underfunded and underprioritized, even in high-income countries, with clinical services and prevention/early intervention research receiving minimal investment. Addressing mental health in children and young people requires multi-level strategies beyond individual treatment, including tackling structural and socioeconomic barriers and creating opportunities for strengthening resilience and well-being. A well-trained workforce, adequate policies, and increased public awareness are crucial. Overall, the current gaps demand urgent action and global funding rebalancing to more adequately meet the critical needs of children and young people challenged by mental illness.
引用
- Cortese S, Arango C, Aymerich C, et al. Child and adolescent psychiatry: challenges, solutions, opportunities, and future directions. World Psychiatry. 2026. PMID: 42136439. doi:10.1002/wps.70044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。